glp-1 pharmacokinetics Frontiers This figure schematically illustrates the

Finally, at 24 months, the MD was 1.42 (95% CI: 2.43, 0.41) with 54% heterogeneity ( I 2 ) and a p -value of 0.002

The physiological mechanisms that contributed to weight regulation before starting medicationincluding hormonal signals, proposed metabolic set points, and appetite regulationtypically reassert themselves

They are particularly valuable for patients with established cardiovascular disease, heart failure, or chronic kidney disease

GLP-1 receptor agonists fall far outside that category

GLP-1 drugs are primarily recommended for: Adults with type 2 diabetes who arent seeing results from oral medications and need better blood sugar control People with obesity or with a BMI over 30 (with or without diabetes) seeking medical weight management Doctors may also consider GLP-1 RAs for patients with cardiovascular risk factors, as some of these drugs have shown heart-protective benefits

But heres something many forget The maximum safe rate for peripheral IV KCl is 10 mEq per hour